UCSD
La Jolla, California, 92093, United States
NCT Number: NCT00796939
This study will determine if green light exposure during sleep is effective in reducing mild depression symptoms in young men.
Looking for future studies?
Notify Me25 year–60 year
Male
Interventional
Not applicable
La Jolla, California, 92093, United States
The circadian rhythm is the human body's internal clock. It affects sleeping and wakefulness patterns. Some scientists theorize that a disruption of circadian rhythms, or other circadian abnormalities, can cause a depressed state. Light received through the eyes can alter the circadian rhythm, and sustained exposure to artificial bright light during the last half of usual sleep time can change the phase of the circadian rhythm. Several studies have found that exposure to bright white light in the morning hours is an effective treatment for depression, especially during the first week of depression treatment. Other studies have shown that green or blue light is preferable to yellow or red light in depression treatment. This study will expose young men to different types of light during the last part of their sleep cycle to determine whether the treatment is safe and tolerable and whether it reduces mood disturbance and depression. The study will also determine the light's effect on the production of luteinizing hormone (LH) and testosterone, hormones that may play a role in depression.
Participation in this study will last 15 days. At the beginning of the study, participants will be provided with study materials and instructed in their use. These materials will include a wrist actigraph, which is a sleep and wakefulness monitoring device similar to a wristwatch; a binder containing instructions, questionnaires, and forms; and a light mask. Participants will be randomly assigned to receive a light mask with either intense green or dim red light. Participants will wear the wrist actigraph throughout the study. For the first 3 days of the study, participants will sleep normally and fill out questionnaires and a sleep diary. The questionnaires will measure mood, sleepiness, sleep quality, treatment effects, and sleep time preference. The sleep diary will be a record of time spent sleeping, time it takes to fall asleep, number of times waking during the night, and similar measures. Starting on the third night, participants will wear the light mask when sleeping. Every day participants will fill out the questionnaires and sleep diary, and they will contact the study investigators to ensure compliance and to ask any questions. Participants will also provide saliva and urine samples once at the beginning and once at the end of the study. These samples will be used to test for testosterone and LH, respectively.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
Participants will receive approximately 10,000 lux from green light-emitting diodes.
Participants will receive approximately 0.5 lux from white light-emitting diodes covered by a red gel.
Time frame: Measured on Days 3 and 15
Time frame: Measured daily for the length of the study
Time frame: Measured on Days 3 and 15
Time frame: Measured daily for the duration of the study
Time frame: Measured daily for the duration of the study
Time frame: Measured on Days 3 and 13
Time frame: Measured on Days 3 and 13
University of California, San Diego
Other
Randomized, Placebo-Controlled Trial of Short Wavelength Light Administered Just Prior to Waking in Young Men
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03363529
Behavior, Behavioral Symptoms
Copenhagen, Denmark
View Trial DetailsNCT05346588
Anesthesia, Anesthesia Awareness
Stanford, California, United States
View Trial DetailsNCT03205033
Behavior, Behavioral Symptoms
View Trial DetailsNCT06644573
Alzheimer Disease, Alzheimer Disease or Associated Disorder
Aventura, Florida, United States
View Trial Details